Back to Blog

Oncology

Blog

How AI and Patient-Level Data Help Oncology Teams Define New Markets

September 8, 2026
Oncology markets are no longer defined only by tumor type or line of therapy. AI, patient-level data, and primary research now help teams define markets by biology, care pathways, and access barriers. That shift can shape development strategy, trial design, and...
Person interacting with with technology
Blog

2025 Oncology Mid-Year Check-in: Reflections & Expectations

June 20, 2025
Reflecting on the first half of 2025 including data from AACR, ASCO and EHA, we see several notable trends continuing to shape the oncology landscape. While development follows momentum observed the last few years, these learnings provide a clearer understanding into...
Hug with Cancer patient and her daughter
Blog

Maximum Fair Price Round 2: Passing the Baton

January 24, 2025
On January 20, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the set of fifteen drugs targeted for the second round of Maximum Fair Price (MFP) “negotiations” under the Inflation Reduction Act (IRA). With the outcomes of the first...
Passing the baton
Blog

Priced Out: Generic Therapy Price Competition and Drug Shortages

January 29, 2024
Introduction In the summer of 2023, many oncologists and cancer patients faced an impossible choice. Amidst many challenging treatment decisions, they had to determine how to proceed without two mainstays among oncology therapeutics: cisplatin and carboplatin. While it can sometimes be...
Blog

Key Takeaways and Learnings from ASH 2023

January 12, 2024
Introduction The Trinity Life Sciences’ team recently attended the 65th ASH Annual Meeting and Exposition from December 9-12, 2023, in San Diego, California. The conference brought together physicians, scientists and industry experts to share and collaborate on advances in understanding and...
Blog

The Enhancing Oncology Care Model: Where Public Health Meets Oncology Care

November 7, 2022
  Executive Summary Introduction The OCM has recently concluded after five years of existence. Institutional participants advocated for a follow-up model – and following numerous reviews and analyses of the successes and points of improvement of the OCM, Centers for Medicare...
Blog

Poland’s Medical Fund Bill to Improve Access to Oncology Drugs

June 2, 2021
  Executive Summary Trinity’s Take: The recently introduced Medical Fund Bill has potential to improve access to novel therapies applying for reimbursement in Poland, however, it is yet to be seen how the criteria for inclusion in the Fund’s list are clarified...
Poland’s Medical Fund Bill to Improve Access to Oncology Drugs
Back To Top